References
- Alavijeh MS, Palmer AM. (2010). Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds. Neurobiol Dis 37:38–47
- Cao SL, Zhang QZ, Jiang XG. (2007). Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacy. Acta Pharmacol Sin 28:584–90
- Hyde RW, Tonndorf J, Chinn HE. (1953). Absorption from the nasal mucous membrane. Ann Otol Rhinol Laryngol 62:957–68
- Illum L. (2000). Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11:1–18
- Jiang XG, Cui JB, Fang XL, et al. (1995). Toxicity of drugs on nasal mucocilia and the method of its evaluation. Acta Pharm Sin 30:848–53
- Lu W, Jiang W, Chen J, et al. (2008). Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride. Int J Pharm 349:196–205
- Melgaard L, Hersini KJ, Gazerani P, Petersen LJ. (2013). Retrodialysis: a review of experimental and clinical applications of reverse microdialysis in the skin. Skin Pharmacol Physiol 26:160–74
- Mittal D, Ali A, Md S, et al. (2014). Insights into direct nose to brain delivery: current status and future perspective. Drug Deliv 21:75–86
- Nachum Z, Shahal B, Shupak A, et al. (2001). Scopolamine bioavailability in combined oral and transdermal delivery. J Pharmacol Exp Ther 296:121–3
- Navailles S, Lagière M, Contini A, De Deurwaerdère P. (2013). Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain. ACS Chem Neurosci 4:680–92
- Oman CM. (1990). Motion sickness: a synthesis and evaluation of the sensory conflict theory. Can J Physiol Pharmacol 68:294–303
- Reason JT. (1970). Motion sickness: a special case of sensory rearrangement. Adv Sci 26:386–93
- Reason JT, Brand JJ. (1975). Motion sickness. : Academic Press
- Renner UD, Oertel R, Kirch W. (2005). Pharmacokinetics and pharmacodynamics in clinical use of Scopolamine. Ther Drug Monit 27:655–65
- Robert F, Bert L, Lambas-Senas L, et al. (1996). In vivo monitoring of extracellular noradrenaline and glutamate from rat brain cortex with 2-min microdialysis sampling using capillary electrophoresis with laser-induced fluorescence detection. J Neurosci Methods 70:153–62
- Shannon RJ, Carpenter KL, Guilfoyle MR, et al. (2013). Cerebral microdialysis in clinical studies of drugs: pharmacokinetic applications. J Pharmacokinet Pharmacodyn 40:343–58
- Spinks A, Wasiak J. (2011). Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev 6:CD002851
- Thornton WE, Bonato F. (2013). Space motion sickness and motion sickness: symptoms and etiology. Aviat Space Environ Med 84:716–21
- Wang F, Jiang XG, Lu W. (2003). Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats. Int J Pharm 263:1–7
- Yardley L. (1992). Motion sickness and perception: a reappraisal of the sensory conflict approach. Br J Psychol 83:449–71